Name : Mr. AKSHIT Patient UID.

: 6612263
Age/Gender : 13 Yrs/Male Visit No. : 00202412150004
Referred Client : LDPL005C-LDPL005C Collected on : 15-Dec-2024 10:00AM
Referred By : SELF Received on : 15-Dec-2024 12:33PM
Doctor Name : Reported on : 15-Dec-2024 12:47PM
Sample Type : Whole Blood EDTA - 16965429,Serum - 16965428

HAEMATOLOGY
Test Name Results Unit Bio. Ref. Interval
COMPLETE BLOOD COUNT (CBC),WHOLE BLOOD EDTA
HAEMOGLOBIN (Hb) 13 g/dL 13.0-17.0
Methodology: colorimetric method
RED BLOOD CELLS- RBC COUNT 4.79 millions/mm³ 4.5 - 5.5
Methodology: electric impedance
PACKED CELL VOLUME (PCV) -HEMATOCRIT 39.9 % 40.0-50.0
Methodology: Pulse Height detection method
MCV 83.3 fL 83-101
Methodology: Automated/Calculated
MCH 27.14 pg 27.0-32.0
Methodology: by Automated/Calculated
MCHC 32.58 g/dL 31.5-34.5
Methodology: Automated/Calculated
RED CELL DISTRIBUTION WIDTH (RDW-CV) 13.8 % 11.6-14.0
Methodology: Automated/Calculated
RED CELL DISTRIBUTION WIDTH (RDW-SD) 44.4 fL 39.0- 46.0
Methodology: Automated/Calculated
MENTZER INDEX 17.39
Methodology: Calculated
PLATELET COUNT 199 10^3/µL 150-410
Methodology: Electric impedance/Microscopy
PLATELET DISTRIBUTION WIDTH (PDW) 16.5 fL 9.00-17.00
Methodology: Calculated
PCT(PLATELETCRIT) 0.21 % 0.108-0.282
Methodology: Calculated
MEAN PLATELET VOLUME - MPV 10.5 fL 7.00-12.0
Methodology: Calculated
P-LCR 28.90 % 11.0-45.0
Methodology: Calculated
P-LCC 58.00 % 30.0-90.0
Methodology: Calculated
TOTAL LEUKOCYTE COUNT (TLC) 3.37 10^3/µL 4.00-10.0
Methodology: electric impedance
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils 54.8 % 40 - 75
Methodology: Flow cytometry/Manual
Lymphocytes 35.6 % 28 - 48
Methodology: Flow cytometry/Manual
Eosinophils 1.1 % 1.00-6.00

Page 1 of 4
 Name : Mr. AKSHIT Patient UID. : 6612263
Age/Gender : 13 Yrs/Male Visit No. : 00202412150004
Referred Client : LDPL005C-LDPL005C Collected on : 15-Dec-2024 10:00AM
Referred By : SELF Received on : 15-Dec-2024 12:33PM
Doctor Name : Reported on : 15-Dec-2024 12:47PM
Sample Type : Whole Blood EDTA - 16965429,Serum - 16965428
Methodology: Flow cytometry/Manual
Monocytes 7.9 % 2.00-10.0
Methodology: Flow cytometry/Manual
Basophils 0.6 % 0.00-1.00
Methodology: Flow cytometry/Manual
ABSOLUTE NEUTROPHIL COUNT 1.85 10^3/µL 2.00-7.00
Methodology: Calculated
ABSOLUTE LYMPHOCYTE COUNT 1.2 10^3/µL 1.00-3.00
ABSOLUTE EOSINOPHIL COUNT 0.04 10^3/µL 0.02-0.50
Methodology: Calculated
ABSOLUTE MONOCYTE COUNT 0.27 10^3/µL 0.20-1.00
Methodology: Calculated
ABSOLUTE BASOPHIL COUNT 0.02 10^3/µL 0.02-0.10
Methodology: Calculated
CLINICAL NOTES
A complete blood count (CBC) is used to evaluate overall health and detect wide range of disorders, including anemia, infection and leukemia.
There have been some reports of WBC and platelet counts being lower in venous blood than in capillary blood samples ,although still within these reference ranges.

POSSIBLE CAUSES OF ABNORMAL PARAMETERS:-

High RBC, Hb, or HCT - dehydration, polycythemia, shock, chronic hypoxia
Low RBC, Hb, or HCT - anemia, thalassemia, and other hemoglobinopathies
Low MCV - microcytic anemia
High MCV - macrocytic anemia, liver disease
Low WBC - sepsis, marrow hypoplasia
High WBC - acute stress, infection, malignancies
Low platelets - risk of bleeding
High platelets - risk of thrombosis

Notes
1.Macrocytic Anemia/Dimorphic Anemia can have low platelet count.
2.Microcytic Anemia/Leucocytosis can have Reactive thrombocytosis.

For microcytic indices a Mentzer index of less than 13 suggests that the patient may have thalassemia trait, and an index of more than 13 suggests that the patient may
have iron deficiency.

Reference ranges are from Dacie and Lewis Practical Hematology 11th edition(2011)

*** End Of Report ***

Page 2 of 4
 Name : Mr. AKSHIT Patient UID. : 6612263
Age/Gender : 13 Yrs/Male Visit No. : 00202412150004
Referred Client : LDPL005C-LDPL005C Collected on : 15-Dec-2024 10:00AM
Referred By : SELF Received on : 15-Dec-2024 12:33PM
Doctor Name : Reported on : 15-Dec-2024 01:24PM
Sample Type : Whole Blood EDTA - 16965429,Serum - 16965428

BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
CREACTIVE PROTEIN - CRP (QUANTITATIVE)
CREACTIVE PROTEIN - CRP 21.10 mg/L 0-5
(QUANTITATIVE),Serum
Methodology: Turbidimetric
CLINICAL NOTES
CRP is an acute phase reactant, a protein made by the liver and released into the blood within a few hours after tissue injury, the start of an infection, or other cause of
inflammation. The CRP test is not diagnostic of any condition, but it can be used together with signs and symptoms and other tests to evaluate an individual for an acute or
chronic inflammatory condition.For example, CRP may be used to detect or monitor significant inflammation in an individual who is suspected of having an acute condition,
such as:A serious bacterial infection like sepsis, fungal infection,Pelvic inflammatory disease (PID).

Markedly increased levels can occur, for example, after trauma or a heart attack, with active or untreated autoimmune disorders, and with serious bacterial infections,
such as in sepsis. The level of CRP can jump as much as a thousand-fold in response to bacterial infection, and its rise in the blood can precede pain, fever, or other signs
and symptoms.

The CRP test is useful in monitoring people with chronic inflammatory conditions to detect flare-ups and/or to determine if treatment is effective. Some examples
include:Inflammatory bowel disease,Some forms of arthritis,Autoimmune diseases, such as lupus or vasculitis.

CRP may sometimes be ordered along with erythrocyte sedimentation rate (ESR), another test that detects inflammation. While the CRP test is not specific enough to
diagnose a particular disease, it does serve as a general marker for infection and inflammation, thus alerting health practitioners that further testing and treatment may be
necessary. Depending on the suspected cause, a number of other tests may be performed to identify the source of inflammation.

Interpretation of CRP levels:-

Refrence National library of Medicine-C Reactive Protein Sara M. Nehring; Amandeep Goyal; Bhupendra C. Patel(Last Update: July 18, 2022)
Less than 3 mg/L: Normal (level seen in most healthy adults).
3 to 10 mg/L: Normal or minor elevation (can be seen in obesity, pregnancy, depression, diabetes, common cold, gingivitis, periodontitis, sedentary lifestyle, cigarette
smoking, and genetic polymorphisms).
10 to 100 mg/L: Moderate elevation (Systemic inflammation such as RA, SLE, or other autoimmune diseases, malignancies, myocardial infarction, pancreatitis, bronchitis).
More than 100 mg/L: Marked elevation (Acute bacterial infections, viral infections, systemic vasculitis, major trauma).
More than 500 mg/L: Severe elevation (Acute bacterial infections).

Page 3 of 4
 Name : Mr. AKSHIT Patient UID. : 6612263
Age/Gender : 13 Yrs/Male Visit No. : 00202412150004
Referred Client : LDPL005C-LDPL005C Collected on : 15-Dec-2024 10:00AM
Referred By : SELF Received on : 15-Dec-2024 12:33PM
Doctor Name : Reported on : 15-Dec-2024 01:08PM
Sample Type : Whole Blood EDTA - 16965429,Serum - 16965428

SEROLOGY
Test Name Results Unit Bio. Ref. Interval
TYPHI DOT- IGM: SALMONELLA TYPHI
TYPHI DOT- IGM: SALMONELLA TYPHI NEGATIVE Negative
Methodology: Lateral FlowChomatograpy
CLINICAL NOTES
Typhi dot is a rapid test for detection of IgM antibodies to Salmonella typhi. Accurate diagnosis of Typhoid fever at an early stage is not only important for etiological
diagnosis, but also to identify and treat potential carriers and prevent acute typhoid fever outbreaks. The conventional Widal test detects antibodies to S .typhi in patient
serum from the second week of onset of symptoms where

Note
1.Low titre of IgM antibodies to S.typhi may persist for about 4 months post infection in endemic areas.
2.All results to be clinically correlated

*** End Of Report ***

Page 4 of 4